|
Real-time
Boerse Muenchen
11:13:28 19/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 61.70 EUR | -0.88% |
|
-2.12% | +30.50% |
| 06/08 | Defense: after the stampede into the sector, it's time to make choices | |
| 06/08 | Defense: after the rush into the sector, it is time to make choices |
| Market Cap | 316.92Cr 369.46Cr 295.93Cr 271.51Cr 510.57Cr 35TCr 518.98Cr 3.49TCr 1.37TCr 18TCr 1.39TCr 1.36TCr 59TCr | P/E 2026 * |
38.1x | P/E 2027 * | 28.6x |
|---|---|---|---|---|---|
| Enterprise Value | 332.94Cr 388.13Cr 310.89Cr 285.23Cr 536.38Cr 37TCr 545.21Cr 3.67TCr 1.44TCr 19TCr 1.46TCr 1.43TCr 62TCr | EV / Sales 2026 * |
6.18x | EV / Sales 2027 * | 5.33x |
| Free-Float |
68.96% | Yield 2026 * |
0.57% | Yield 2027 * | 0.78% |
Last Transcript: Exosens
| 1 week | -2.12% | ||
| Current month | +9.02% | ||
| 1 month | +10.37% | ||
| 3 months | +6.96% | ||
| 6 months | +3.92% | ||
| Current year | +30.50% |
| 1 week | 61.7 | 66.95 | |
| 1 month | 56.35 | 66.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jérôme Cerisier
CEO | Chief Executive Officer | 53 | 01/09/2016 |
| Director of Finance/CFO | 53 | 01/04/2022 | |
| Chief Tech/Sci/R&D Officer | - | 01/07/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jérôme Cerisier
BRD | Director/Board Member | 53 | - |
Brigitte Geny
BRD | Director/Board Member | - | - |
Jean-Hubert Vial
CHM | Chairman | 56 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.88% | -2.12% | +50.36% | - | 366.93Cr | ||
| -4.65% | -1.75% | +34.98% | +220.43% | 39TCr | ||
| -1.32% | -0.08% | +44.86% | +160.28% | 30TCr | ||
| -1.20% | -1.72% | +43.41% | +652.55% | 17TCr | ||
| -1.82% | -1.70% | +35.21% | +32.10% | 14TCr | ||
| +0.16% | +0.03% | +24.63% | +75.82% | 11TCr | ||
| -2.92% | -4.85% | +25.51% | +124.86% | 8.53TCr | ||
| +0.12% | +2.17% | +0.62% | +36.01% | 8.37TCr | ||
| -2.88% | +0.91% | -24.82% | +373.41% | 6.56TCr | ||
| -0.26% | -4.04% | +2.48% | +54.20% | 5.21TCr | ||
| Average | -1.63% | +1.23% | +23.72% | +192.19% | 15.54TCr | |
| Weighted average by Cap. | -2.20% | +1.25% | +30.81% | +215.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 54Cr 63Cr 50Cr 46Cr 87Cr 6TCr 88Cr 593.57Cr 232.43Cr 3.01TCr 235.81Cr 230.68Cr 9.95TCr | 61Cr 72Cr 57Cr 53Cr 99Cr 6.85TCr 100.62Cr 677.01Cr 265.1Cr 3.43TCr 268.96Cr 263.1Cr 11TCr |
| Net income | 8.04Cr 9.37Cr 7.5Cr 6.88Cr 13Cr 895.33Cr 13Cr 89Cr 35Cr 449.04Cr 35Cr 34Cr 1.48TCr | 11Cr 13Cr 10Cr 9.28Cr 17Cr 1.21TCr 18Cr 119.3Cr 47Cr 605.09Cr 47Cr 46Cr 2TCr |
| Net Debt | 16Cr 19Cr 15Cr 14Cr 26Cr 1.79TCr 26Cr 176.51Cr 69Cr 895.25Cr 70Cr 69Cr 2.96TCr | 10Cr 12Cr 9.68Cr 8.88Cr 17Cr 1.15TCr 17Cr 114.18Cr 45Cr 579.09Cr 45Cr 44Cr 1.91TCr |
| Date | Price | Change |
|---|---|---|
| 19/26/19 | €61.70 | -0.88% |
| 18/26/18 | €62.25 | -3.79% |
| 17/26/17 | €64.70 | -3.36% |
| 14/26/14 | €66.95 | +6.44% |
| 13/26/13 | €62.90 | -3.68% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EXENS Stock
- H8Y Stock
Select your edition
All financial news and data tailored to specific country editions

















